A detailed history of Prudential Financial Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Prudential Financial Inc holds 19,315 shares of RPRX stock, worth $487,317. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,315
Previous 21,084 8.39%
Holding current value
$487,317
Previous $555,000 1.62%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$25.63 - $29.27 $45,339 - $51,778
-1,769 Reduced 8.39%
19,315 $546,000
Q2 2024

Aug 13, 2024

BUY
$26.26 - $29.9 $78,780 - $89,700
3,000 Added 16.59%
21,084 $555,000
Q1 2024

May 14, 2024

BUY
$27.46 - $31.33 $158,554 - $180,899
5,774 Added 46.9%
18,084 $549,000
Q4 2023

Feb 13, 2024

SELL
$26.21 - $29.22 $68,146 - $75,972
-2,600 Reduced 17.44%
12,310 $345,000
Q3 2023

Nov 13, 2023

SELL
$26.26 - $31.38 $10,504 - $12,552
-400 Reduced 2.61%
14,910 $404,000
Q2 2023

Aug 11, 2023

BUY
$29.6 - $36.56 $142,080 - $175,488
4,800 Added 45.67%
15,310 $470,000
Q4 2022

Feb 14, 2023

SELL
$39.17 - $44.04 $150,216 - $168,893
-3,835 Reduced 26.73%
10,510 $0
Q3 2022

Nov 04, 2022

BUY
$39.88 - $44.65 $120,038 - $134,396
3,010 Added 26.55%
14,345 $576,000
Q2 2022

Aug 15, 2022

SELL
$37.53 - $44.22 $340,960 - $401,738
-9,085 Reduced 44.49%
11,335 $477,000
Q1 2022

May 13, 2022

SELL
$37.46 - $42.44 $470,684 - $533,258
-12,565 Reduced 38.09%
20,420 $796,000
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $464,947 - $561,585
13,220 Added 66.89%
32,985 $1.31 Million
Q3 2021

Nov 15, 2021

BUY
$36.14 - $42.24 $357,786 - $418,176
9,900 Added 100.35%
19,765 $714,000
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $65,553 - $76,706
1,645 Added 20.01%
9,865 $404,000
Q1 2021

May 12, 2021

BUY
$42.34 - $52.82 $348,034 - $434,180
8,220 New
8,220 $359,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.